Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,529-3,540 of 4,306
Drug study icon
CompletedNCT01299454

A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Miami
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT04294719

Cognitive Adaptation Training in Inpatient Forensic Environments

This study is completed in Canada. It is testing cognitive Adaptation Training for Schizophrenia.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
CompletedNCT03345342

Paliperidone Palmitate 6-Month Formulation

This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00249171

Risperidone for Schizophrenia

This study is completed. It is testing risperidone for Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 16 Years
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
Schizophrenia
Drug study icon
CompletedNCT00791167

The Dose Proportionality of Extended Release Paliperidone

This study is completed. It focuses on Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.